DK2118136T3 - Konsensuspeptid - Google Patents
KonsensuspeptidInfo
- Publication number
- DK2118136T3 DK2118136T3 DK07866581.7T DK07866581T DK2118136T3 DK 2118136 T3 DK2118136 T3 DK 2118136T3 DK 07866581 T DK07866581 T DK 07866581T DK 2118136 T3 DK2118136 T3 DK 2118136T3
- Authority
- DK
- Denmark
- Prior art keywords
- consensus peptide
- biomineralization
- mineralization
- stimulation
- induction
- Prior art date
Links
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 3
- 230000033558 biomineral tissue development Effects 0.000 abstract 4
- 230000006698 induction Effects 0.000 abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 2
- 230000000638 stimulation Effects 0.000 abstract 2
- 238000000338 in vitro Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K17/00—Carrier-bound or immobilised peptides; Preparation thereof
- C07K17/14—Peptides being immobilised on, or in, an inorganic carrier
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Toxicology (AREA)
- Physical Education & Sports Medicine (AREA)
- Inorganic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Rheumatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Materials For Medical Uses (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Polyamides (AREA)
- Dental Preparations (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87614906P | 2006-12-21 | 2006-12-21 | |
| PCT/IB2007/004068 WO2008078167A2 (en) | 2006-12-21 | 2007-12-21 | Consensus peptide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2118136T3 true DK2118136T3 (da) | 2010-11-15 |
Family
ID=39387381
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK07866581.7T DK2118136T3 (da) | 2006-12-21 | 2007-12-21 | Konsensuspeptid |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US8367602B2 (da) |
| EP (1) | EP2118136B1 (da) |
| JP (1) | JP5253412B2 (da) |
| KR (2) | KR101493437B1 (da) |
| AT (1) | ATE475670T1 (da) |
| AU (1) | AU2007337797B2 (da) |
| CA (1) | CA2673382C (da) |
| DE (1) | DE602007008147D1 (da) |
| DK (1) | DK2118136T3 (da) |
| ES (1) | ES2349889T3 (da) |
| HK (1) | HK1137186A1 (da) |
| PL (1) | PL2118136T3 (da) |
| WO (1) | WO2008078167A2 (da) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2011111832A1 (ja) * | 2010-03-11 | 2011-09-15 | 独立行政法人理化学研究所 | ポリペプチド配列の選択方法、並びに金属酸化物または含珪素化合物結合ペプチドおよびその利用 |
| SE537635C2 (sv) | 2012-09-18 | 2015-08-25 | Corticalis As | Metod för att producera en alginatbelagd titandioxidscaffold, denna titandioxidscaffold samt medicinskt implantatinnefattande scaffolden |
| EP4125993A4 (en) * | 2020-03-26 | 2024-04-24 | Bone Sci. Bio Ltd. | Pharmaceutical compositions comprising amphiphilic peptides and methods of use thereof |
| EP4487834A1 (en) | 2023-07-07 | 2025-01-08 | NuPep AS | Consensus peptides in hya |
| WO2025012149A1 (en) | 2023-07-07 | 2025-01-16 | Nupep As | Consensus peptides in hya |
| EP4487863A1 (en) | 2023-07-07 | 2025-01-08 | NuPep AS | Consensus peptides in hya for use in treating degenerated joints |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5786327A (en) | 1993-03-12 | 1998-07-28 | Gensci Regeneration Sciences Inc. | Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same |
| IL108947A0 (en) * | 1993-03-12 | 1994-06-24 | Osteopharm Ltd | Bone stimulating factor |
| US7132015B2 (en) | 2002-02-20 | 2006-11-07 | University Of Southern California | Materials for dental and biomedical application |
| KR101206345B1 (ko) | 2004-12-10 | 2012-12-06 | 스트라우만 홀딩 에이쥐 | 신규한 단백질 배합물 |
| US8796417B2 (en) * | 2005-05-27 | 2014-08-05 | Japan Science And Technology Agency | Three-dimensional structure of functional material |
-
2007
- 2007-12-21 DK DK07866581.7T patent/DK2118136T3/da active
- 2007-12-21 DE DE602007008147T patent/DE602007008147D1/de active Active
- 2007-12-21 KR KR1020097015360A patent/KR101493437B1/ko active IP Right Grant
- 2007-12-21 US US12/520,651 patent/US8367602B2/en active Active
- 2007-12-21 AU AU2007337797A patent/AU2007337797B2/en not_active Ceased
- 2007-12-21 JP JP2009542264A patent/JP5253412B2/ja active Active
- 2007-12-21 CA CA2673382A patent/CA2673382C/en not_active Expired - Fee Related
- 2007-12-21 AT AT07866581T patent/ATE475670T1/de not_active IP Right Cessation
- 2007-12-21 WO PCT/IB2007/004068 patent/WO2008078167A2/en active Application Filing
- 2007-12-21 ES ES07866581T patent/ES2349889T3/es active Active
- 2007-12-21 KR KR1020147036230A patent/KR20150014999A/ko not_active Application Discontinuation
- 2007-12-21 EP EP07866581A patent/EP2118136B1/en active Active
- 2007-12-21 PL PL07866581T patent/PL2118136T3/pl unknown
-
2010
- 2010-05-14 HK HK10104769.9A patent/HK1137186A1/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20100172949A1 (en) | 2010-07-08 |
| DE602007008147D1 (de) | 2010-09-09 |
| JP2010513460A (ja) | 2010-04-30 |
| KR20090117702A (ko) | 2009-11-12 |
| KR101493437B1 (ko) | 2015-02-16 |
| ES2349889T3 (es) | 2011-01-12 |
| HK1137186A1 (en) | 2010-07-23 |
| AU2007337797B2 (en) | 2012-08-23 |
| WO2008078167A2 (en) | 2008-07-03 |
| US8367602B2 (en) | 2013-02-05 |
| PL2118136T3 (pl) | 2011-04-29 |
| EP2118136B1 (en) | 2010-07-28 |
| KR20150014999A (ko) | 2015-02-09 |
| WO2008078167A3 (en) | 2008-08-21 |
| AU2007337797A1 (en) | 2008-07-03 |
| EP2118136A2 (en) | 2009-11-18 |
| JP5253412B2 (ja) | 2013-07-31 |
| CA2673382A1 (en) | 2008-07-03 |
| CA2673382C (en) | 2016-03-29 |
| ATE475670T1 (de) | 2010-08-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY158325A (en) | Multitype peptide compositions and methods for treatment or prevention of human papillpmavirus infection | |
| JO2976B1 (en) | Axentomodulin polypeptide | |
| MX357801B (es) | Agentes dirigidos a gadd45beta. | |
| TN2012000303A1 (en) | Oxyntomodulin peptide analogue | |
| DK3323815T3 (en) | Human Protein Tyrosine Phosphatase Inhibitors and Methods of Use | |
| MX2009006466A (es) | Metodos de tratamiento de cancer con inhibidores del receptor del factor 1 de crecimiento similar a la insulina. | |
| UA94221C2 (en) | Lipocalin protein | |
| EA201000865A1 (ru) | Комбинация ингибиторов протеинтирозинфосфатазы и гормона роста человека, предназначенная для лечения атрофии мышц и родственных нарушений | |
| TN2012000512A1 (en) | Compositions and methods of use for therapeutic low density lipoprotein - related protein 6 (lrp6) multivalent antibodies | |
| CY1117582T1 (el) | Χρηση μιμοτοπων των α-συνουκλεϊνης επιτοπων για θεραπεια ασθενειων σωματος lewy | |
| MX2009006327A (es) | Compuestos heterociclicos y metodos de uso de los mismos. | |
| TN2012000511A1 (en) | Compositions and methods of use for therapeutic low density lipoprotein -related protein 6 (lrp6) antibodies | |
| EP2166845A4 (en) | ALPHA CONNEXIN C TERMINAL (ACT) PEPTIDES FOR THE TREATMENT OF AGE-RELATED MACULAR AGENCY | |
| HK1137186A1 (en) | Consensus peptide | |
| HK1142828A1 (en) | Hydrolysable polymeric fmoc-linker | |
| WO2010135521A3 (en) | Compositions and methods for the therapy and diagnosis of influenza | |
| HK1127910A1 (en) | Compositions containing peptides with non-natural amino acids and methods of use | |
| EP2552462A4 (en) | CCN3 THERAPEUTIC PEPTIDES AND THEIR ANALOGS | |
| EP2294197A4 (en) | HHIP1 PROTEIN VERSION AND METHOD AND USES THEREOF | |
| MX2009005550A (es) | Inhibidores de fosfatasa de proteina tirosina para la promocion de la hipertrofia cardiaca fisiologica. | |
| ATE489947T1 (de) | Axomadol zur schmerzbehandlung bei arthrose | |
| MX2010005280A (es) | Nuevos peptidos sinteticos sustituidos con arginina y su uso. | |
| IN2014KN01026A (da) | ||
| MX2009012599A (es) | Mutantes de vegf-d y su uso. | |
| GB201018125D0 (en) | Peptide |